Abstract Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

O
OBESITY, METABOLIC SYNDROME, AND VENOUS THROMBOEMBOLISM
Alessi M.C., Juhan-Vague I.
 
OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
Yun Y., Lim Y., Kim T., Jin Y., Kwon J., Kim D., Lee S., Kwon B., Hong J.
 
OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Basili S., Palmirotta R., Nigro C., Savonarola A., Proietti M., Scarno A., Lisi F., Colicchia A., Rampini M., Ferroni P., Guadagni F.
 
OCCIPITAL BONE COMPRESSION OF THE SUPERIOR SAGITTAL SINUS AS A CONTRIBUTORY FACTOR IN NEONATAL CEREBRAL SINOVENOUS THROMBOSIS
Tan M.A., Shroff M., DeVeber G., Moharir M., Pontigon A., Kirton A.
 
OCCURRENCE, SUBSTRATE SPECIFICITY, CLONING AND BIOINFORMATIC ANALYSES OF HEMORRHAGIC P-III PROTEASE OF RUSSELL'S VIPER VENOM
Tsai I., Chen H., Tsai S.
 
OLIGOSACCHARIDES FROM DIFFERENT LOW MOLECULAR WEIGHT HEPARINS HAVE DIFFERENT ANTICOAGULANT AND PROTAMINE SULPHATE NEUTRALIZATION PROFILES
Hogwood J., Gray E., Johansen K., Schroder M., Mulloy B.
 
ON DEMAND TREATMENT AND CONTINUOUS PROPHYLAXIS OF ADULT HAEMOPHILIA A PATIENTS: A COMPARATIVE RETROSPECTIVE DATA ASCERTAINMENT
Siegmund B., Richter H., Pollmann H.
 
ON THREE CASES OF INHERITABLE FACTOR VII DEFICIENCY
Kolaitis N.I., Koliou P., Dova L., Vartholomatos G., Kapsali H.
 
ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Ni Ainle F.B., Appleby N., Wong A., Byrne B., Regan C., Milner M., Hassan T., Nolan B., White B., O'Donnell J.
 
ONCE-WEEKLY SUBCUTANEOUS IDRAPARINUX (ANTI-XA) VERSUS ORAL VITAMIN K ANTAGONIST THERAPY FOR THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
Büller H.
 
ONE-THIRD OF JAPANESE PATIENTS WITH DEEP VEIN THROMBOSIS CARRIED THE GENETIC MUTATIONS IN PROTEINS S, C AND ANTITHROMBIN GENES: THE SUB-GROUP STUDY OF BLOOD COAGULATION ABNORMALITY, THE STUDY GROUP OF RESEARCH ON MEASURES FOR INTRACTABLE DISEASES IN JAPAN
Ishikawa J., Sato Y., Takeshita S., Kokame K., Kimura R., Honda S., Kawasaki T., Suehisa E., Tsuji H., Madoiwa S., Sakata Y., Kojima T., Murata M., Ikeda Y., Miyata T.
 
OPTIMAL ANTICOAGULANT INTENSITY FOR JAPANESE PATIENTS WITH MECHANICAL VALVE
Murasaki K.M., Omori H., Uetsuka Y., Hagiwara N., Kasanuki H.
 
OPTIMAL DURATION OF ANTICOAGULANT TREATMENT IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Agnelli G.
 
OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Polgar J., Havelick J., Li Q., Laurent N., Mahesh U., Matte D., Gruman Z., Haley P., Doenges E., Holland C.M., Csapo I., Crowley C., Doyle M., Triscott M.
 
OPTIMIZING CARE VIA INTERNET-BASED HEMOPHILIA THERAPY MANAGEMENT PLATFORM
Kachnowski S., Blum R., Capone C., Edwards A., Woolery C.
 
OPTIMIZING rFVIIa TREATMENT
Hulikova M., Hulikova J.
 
ORAL ANTICOAGULATION SEVERELY IMPAIRS THE FUNCTION OF THE PROTEIN C SYSTEM
Carlo A., AlDieri R., Woodhams B., Hemker H.C.
 
ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
Conard J., Plu-Bureau G., Sitruk-Ware R., Menard J., Kumar S., Thalabard J., Tokay B., Bouchard P.
 
ORALLY ADMINISTERED HEPARIN HAS CUMULATIVE ANTITHROMBOTIC EFFECTS WHEN ADMINISTERED IN REPEATED DOSES
Hiebert L.M., Wice S.M., Ping T.
 
ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
Tardy-Poncet B., Wolf M., Lasne D., Alhenc-Gelas M., Camarasa P., Bauters A., Ffrench P., Tardy B.
 
ORIENTIA TSUTSUGAMUSHI INFECTION (SCRUB TYPHUS) IS ASSOCIATED WITH AN INFRACLINICAL ACTIVATION OF THE COAGULATION SYSTEM BUT NOT WITH AN ACTIVATION OF ENDOTHELIAL CELLS
Toulon P.A., Limousin L., Farrugia C., Cuzon G., Burnouf T., Watt G.
 
ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
Quintana M., Bello I.F., Yuste V.J., Román M.A., Garrido J.R., Salces M.M., Navarro F.H.
 
OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
Bernardi E., Camporese G., Verlato F., Scarano L., Palareti G., Ghirarduzzi A., Tomasi C., Prandoni P.
 
OUTCOMES OF THROMBOLYSIS FOR REPEATED COURSES OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR INTRAVASCULAR THROMBOSIS IN CHILDREN
Traivaree C., Brandao L., Chan A., Williams S.
 
OVERALL HAEMOSTASIS POTENTIAL IN PATIENTS WITH VENOUS THROMBOSIS BEFORE, DURING AND AFTER ANTICOAGULANT TREATMENT
Vizintin Cuderman T., Bozic M., Antovic A., Peternel P., Stegnar M.
 
OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS
Alexandra J., Pautas E., Gouin-Thibault I., Gouronnec A., Le Strat N., Siguret V.
 
OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL
Niiya M., Endo M., Shang D., Zoltick P.W., Muvarak N.E., Flake A.W., Zheng X.
 
OVEREXPRESSION OF INFLAMMATORY FACTORS ASSOCIATED WITH PROTHROMBOTIC STATE IN LEUKEMIA PATIENTS
Gu J.
 
OVERWEIGHT IN DUTCH HAEMOPHILIA PATIENTS
Peters M., Hofstede F.F.G., Kamphuisen P.P.W., Fijnvandraat K.K., Plug I.I.
 
OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
Santilli F., Falco A., Basili S., Dragani A., Rolandi G., Lattanzio S., Ciabattoni G., Patrono C., Davì G.
 
OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
Pignatelli P., Sanguigni V., Lenti L., Loffredo L., Carnevale R., Sorge R., Perri L., Violi F.
 
| ISTH 2009